Cargando…

Assisted delivery of antisense therapeutics in animal models of heritable neurodegenerative and neuromuscular disorders: a systematic review and meta-analysis

Antisense oligonucleotide (AON)-based therapies hold promise for a range of neurodegenerative and neuromuscular diseases and have shown benefit in animal models and patients. Success in the clinic is nevertheless still limited, due to unfavourable biodistribution and poor cellular uptake of AONs. Ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Bent, M. Leontien, Paulino da Silva Filho, Omar, van Luijk, Judith, Brock, Roland, Wansink, Derick G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843643/ https://www.ncbi.nlm.nih.gov/pubmed/29520012 http://dx.doi.org/10.1038/s41598-018-22316-7

Ejemplares similares

Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1
por: El Boujnouni, Najoua, et al.
Publicado: (2023)

Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries
por: Castro, Ana F., et al.
Publicado: (2020)

Delivery of antisense oligonucleotides for splice‐correction of androgen receptor pre‐mRNA in castration‐resistant prostate cancer models using cell‐penetrating peptides
por: Luna Velez, Maria V., et al.
Publicado: (2022)

Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat
por: Gudde, Anke E. E. G., et al.
Publicado: (2017)

Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
por: Sardone, Valentina, et al.
Publicado: (2017)

Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro
por: González-Barriga, Anchel, et al.
Publicado: (2017)

Antisense Gene Silencing: Therapy for Neurodegenerative Disorders?
por: Nielsen, Troels T., et al.
Publicado: (2013)

Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders
por: Gomez Limia, Cintia, et al.
Publicado: (2022)

Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases
por: Paoli, Antonio, et al.
Publicado: (2014)

Antisense Transcription in Loci Associated to Hereditary Neurodegenerative Diseases
por: Zucchelli, Silvia, et al.
Publicado: (2019)

How Can Systematic Reviews Teach Us More about the Implementation of the 3Rs and Animal Welfare?
por: Ritskes-Hoitinga, Merel, et al.
Publicado: (2019)

Recent Advances in Antisense Oligonucleotide Therapy in Genetic Neuromuscular Diseases
por: Verma, Ashok
Publicado: (2018)

Editorial: Epigenetics of Neurodevelopmental, Neuromuscular and Neurodegenerative Disorders
por: Coppedè, Fabio, et al.
Publicado: (2022)

Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases
por: Lin, Mengsi, et al.
Publicado: (2021)

Somatic CTG•CAG repeat instability in a mouse model for myotonic dystrophy type 1 is associated with changes in cell nuclearity and DNA ploidy
por: van den Broek, Walther JAA, et al.
Publicado: (2007)

Expanded CUG repeats in DMPK transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences
por: van Cruchten, Remco T.P., et al.
Publicado: (2019)

The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy
por: Deneubourg, Celine, et al.
Publicado: (2021)

(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage
por: André, Laurène M., et al.
Publicado: (2019)

Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides
por: Sangermano, Riccardo, et al.
Publicado: (2019)

Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides
por: Lin, Te-Lin, et al.
Publicado: (2016)

Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
por: Tsoumpra, Maria K., et al.
Publicado: (2019)

Systemic cell therapy for muscular dystrophies: The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy
por: Ausems, C. Rosanne M., et al.
Publicado: (2020)

Neuromuscular monitoring: An assistant not an alternative
por: Tak, Himani, et al.
Publicado: (2018)

Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases
por: Helm, Jacob, et al.
Publicado: (2022)

Assessing the application of the 3Rs: a survey among animal welfare officers in The Netherlands
por: van Luijk, Judith, et al.
Publicado: (2013)

The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes
por: Ciani, Miriam, et al.
Publicado: (2019)

One Health: Animal Models of Heritable Human Bleeding Diseases
por: Dodds, W. Jean
Publicado: (2022)

Application of Urine-Derived Stem Cells to Cellular Modeling in Neuromuscular and Neurodegenerative Diseases
por: Sato, Mitsuto, et al.
Publicado: (2019)

Biophysical analysis of drug efficacy on C. elegans models for neurodegenerative and neuromuscular diseases
por: Sofela, Samuel, et al.
Publicado: (2021)

Systematic Reviews of Animal Studies; Missing Link in Translational Research?
por: van Luijk, Judith, et al.
Publicado: (2014)

Effect of heritable symbionts on maternally-derived embryo transcripts
por: Mateos, Mariana, et al.
Publicado: (2019)

Epigenetics of Animal Personality: DNA Methylation Cannot Explain the Heritability of Exploratory Behavior in a Songbird
por: van Oers, Kees, et al.
Publicado: (2020)

Anti-Tumor Effects of Metformin in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Li, Juan, et al.
Publicado: (2015)

Promise and Pitfalls of Mitochondrial Replacement for Prevention and Cure of Heritable Neurodegenerative Diseases Caused by Deleterious Mutations in Mitochondrial DNA
por: Paine, Ananta, et al.
Publicado: (2016)

Antisense oligonucleotides targeting angiotensinogen: insights from animal studies
por: Wu, Chia-Hua, et al.
Publicado: (2019)

Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
por: André, Laurène M., et al.
Publicado: (2018)

Hydrogel-Assisted Antisense LNA Gapmer Delivery for In Situ Gene Silencing in Spinal Cord Injury
por: Moreno, Pedro M.D., et al.
Publicado: (2018)

Heritability of dietary food intake patterns
por: van den Berg, Linda, et al.
Publicado: (2012)

Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1
por: van der Bent, M Leontien, et al.
Publicado: (2022)

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1h8ikd65sj5ba580i9pj0e485p